Vessel wall imaging features of Moyamoya disease in a North American population: patterns of negative remodelling, contrast enhancement, wall thickening, and stenosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49–68.
Kundishora AJ, Peters ST, Pinard A, Duran D, Panchagnula S, Barak T, Miyagishima DF, Dong W, Smith H, Ocken J, et al. DIAPH1 variants in non-east asian patients with sporadic Moyamoya disease. JAMA Neurol. 2021;78(8):993–1003.
Song JW, Guiry SC, Shou H, Wang S, Witschey WR, Messe SR, Kasner SE, Loevner LA. Qualitative assessment and reporting quality of intracranial vessel wall MR imaging studies: a systematic review. AJNR Am J Neuroradiol. 2019;40(12):2025–32.
Lehman VT, Cogswell PM, Rinaldo L, Brinjikji W, Huston J, Klaas JP, Lanzino G. Contemporary and emerging magnetic resonance imaging methods for evaluation of Moyamoya disease. Neurosurg Focus. 2019;47(6):E6.
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis. Health labour sciences research grant for research on measures for infractable diseases: guidelines for diagnosis and treatment of Moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52(5):245–266.
Kim DK, Verdoorn JT, Gunderson TM, Huston Iii J, Brinjikji W, Lanzino G, Lehman VT. Comparison of non-contrast vessel wall imaging and 3-D time-of-flight MRA for atherosclerotic stenosis and plaque characterization within intracranial arteries. J Neuroradiol. 2020;47(4):266–71.
Mossa-Basha M, de Havenon A, Becker KJ, Hallam DK, Levitt MR, Cohen WA, Hippe DS, Alexander MD, Tirschwell DL, Hatsukami T, et al. Added value of vessel wall magnetic resonance imaging in the differentiation of Moyamoya vasculopathies in a non-asian cohort. Stroke. 2016;47(7):1782–8.
Cogswell PM, Lants SK, Davis LT, Juttukonda MR, Fusco MR, Donahue MJ. Vessel wall and lumen features in north American Moyamoya patients. Clin Neuroradiol. 2020;30(3):545–52.
Kim YJ, Lee DH, Kwon JY, Kang DW, Suh DC, Kim JS, Kwon SU. High resolution MRI difference between Moyamoya disease and intracranial atherosclerosis. Eur J Neurol. 2013;20(9):1311–8.
Ryoo S, Cha J, Kim SJ, Choi JW, Ki CS, Kim KH, Jeon P, Kim JS, Hong SC, Bang OY. High-resolution magnetic resonance wall imaging findings of Moyamoya disease. Stroke. 2014;45(8):2457–60.
Yuan M, Liu ZQ, Wang ZQ, Li B, Xu LJ, Xiao XL. High-resolution MR imaging of the arterial wall in Moyamoya disease. Neurosci Lett. 2015;584:77–82.
Wang M, Yang Y, Zhou F, Li M, Liu R, Guan M, Li R, He L, Xu Y, Zhang B, et al. The contrast enhancement of intracranial arterial wall on high-resolution MRI and its clinical relevance in patients with Moyamoya vasculopathy. Sci Rep. 2017;7:44264.
Kaku Y, Morioka M, Ohmori Y, Kawano T, Kai Y, Fukuoka H, Hirai T, Yamashita Y, Kuratsu J. Outer-diameter narrowing of the internal carotid and middle cerebral arteries in Moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien). 2012;154(12):2151–7.
Muraoka S, Araki Y, Taoka T, Kawai H, Okamoto S, Uda K, Ota S, Naganawa S, Wakabayashi T. Prediction of intracranial arterial stenosis progression in patients with Moyamoya vasculopathy: contrast-enhanced high-resolution magnetic resonance vessel wall imaging. World Neurosurg. 2018;116:e1114–21.
Kathuveetil A, Sylaja PN, Senthilvelan S, Kesavadas C, Banerjee M, Jayanand Sudhir B. Vessel wall thickening and enhancement in high-resolution intracranial vessel wall imaging: a predictor of future ischemic events in Moyamoya disease. AJNR Am J Neuroradiol. 2020;41(1):100–5.
Roder C, Hauser TK, Ernemann U, Tatagiba M, Khan N, Bender B. Arterial wall contrast enhancement in progressive Moyamoya disease. J Neurosurg. 2019;132(6):1845–53.